• Zum Hauptinhalt springen
  • Zum Footer springen
  • Deutsch - de
  • English - en

    SyNergy - Mu...

    • About
      • About us
      • Our Measures
      • Members
      • Cluster Management
      •  PhD & Postdoc representatives
      • Scientific Advisory Board
      •  International cooperation partners
      • Timeline
      •  Media Kit
      • Contact
    • News & Events
      • News
      • Events
      • In the News
      • Open Positions
    • Research
      • Publications
      • Our Research Focus
      • Technology Hubs
      • Research Spotlight
      • Research Data Management
      • Sustainability Initiative
      •  Code of Conduct
    • Science & Society
      • For Schools & Students
      • Public Events
      • Podcasts
      • Videos
    • Support for Diversity & Equity
      • Newcomer Center
      • Gender Equality Program
      • Early Career Investigator Program
    1. Home
    2. News & Events
    3. News
    4. ERC Starting Grant for new SyNergy member Prof. Dr. Lena Burbulla
    News | 03/09/2020 | Press Release, Award

    ERC Starting Grant for new SyNergy member Prof. Dr. Lena Burbulla

    Over 200,000 people in Germany suffer from Parkinson’s disease, a progressive movement disorder that is characterized by the specific loss of nerve cells that synthesize the neurotransmitter dopamine. The absence of dopamine results in an involuntary tremor and sluggish execution of voluntary movements. Starting from skin biopsy samples obtained from Parkinson patients, Lena Burbulla and her colleagues generated induced pluripotent stem cells and differentiated them into dopamine-producing nerve cells in culture. She went on to show that oxidative stress in patient neurons initiates a pathological cascade of events that primarily affects the functions of mitochondria (the “energy powerhouses” of the cell) and lysosomes (the waste disposal and recycling system of the cell). Over time, oxidized versions of dopamine accumulate further exacerbating this toxic cascade.

    In her ERC project entitled “Unraveling the Mystery of Preferential Degeneration of Midbrain Neurons in Neurodegenerative Diseases” (acronym: oxDOPAMINE), Burbulla will attempt to determine why cells in the midbrain in humans are particularly prone to accumulate oxidized dopamine, and hence susceptible to degeneration. Her working hypothesis is that defective dopamine metabolism at the synapses (which transmit nerve impulses), in association with a perturbation of iron metabolism, plays a critical role in this vicious circle. To explore this idea further, she also intends to investigate other, rarer neurodegenerative disorders in which defects in iron metabolism are involved.

    Lena Burbulla studied Biology at LMU and earned her PhD at Tübingen University. She then worked as a postdoctoral fellow at Harvard Medical School, in the Departments of Neurology at Massachusetts General Hospital in Boston, and at the Feinbergine at Northwestern University in Chicago, where she is currently working as Assistant Professor. She was recently awarded a Heisenberg Grant funded by the Deutsche Forschungsgemeinschaft (DFG) and will soon join the SyNergy Cluster of Excellence at LMU, where her ERC project will be carried out.

    • Press release LMU

    Participating Universities
     LMU logo in white
     TUM logo in white
    Partner Institutions
     Logo DZNE in white
    Helmholtz Munich logo in white 
     Logo Max Planck Gesellschaft 

    SyNergy is funded by the Deutsche Forschungsgemeinschaft (German Research Foundation) within the framework of the German Excellence Strategy (EXC 2145 SyNergy – ID 390857198). The Excellence Strategy promotes outstanding research at German universities. 

    Contact

    Munich Cluster for Systems Neurology (SyNergy)

    Feodor-Lynen-Str. 17
    81377 Munich
    +49 (0)89 4400-46497
    yüubgybcјuiWpxј_Wvfulyz-mi
    Editor login
    Imprint | Data-Safety